semaglutide ndc FDA Approves to Reduce Kidney Disease, Cardiovascular Death Risk in Adults With Type 2 Diabetes, Chronic Kidney Disease FDA issues warning about some

Over time, this leads to a natural reduction in calorie intake and, when combined with lifestyle changes, meaningful weight loss

This gradual approach is especially important with retatrutide because it's more potent than current weight loss medications

It might be more than just a hectic schedule you could be dealing with a vitamin B12 deficiency

Shapely is not affiliated with Novo Nordisk, Eli Lilly, or their patient programs

Consider semaglutide if: You prioritize lower cost and established safety data You have a history of GI sensitivity and prefer gradual titration You want to start with the more affordable option (semaglutide at $299/month) You're seeking 15-18% weight loss with solid cardiovascular benefit Consider tirzepatide if: You have more aggressive weight loss goals (20%+ reduction) You have type 2 diabetes or significant cardiometabolic risk Cost is not a primary barrier You tolerate GI side effects well or are willing to manage them Many patients find success on either medication